Avian infectious bronchitis virus (IBV), a group 3 member of the genus Coronavirus (order Nidovirales, family Coronaviridae), is a highly infectious pathogen of domestic fowl that replicates primarily in the respiratory tract but also in epithelial cells of the gut, kidney, and oviduct (10, 13, 14) . Genetically very similar coronaviruses cause disease in turkeys and pheasants (11, 12) . Coronaviruses are enveloped viruses that replicate in the cell cytoplasm and contain an unsegmented, 5Ј-capped and 3Ј-polyadenylated, single-stranded, positive-sense RNA genome of 28 to 32 kb (16, 25, 38) . During the replication cycle, coronaviruses produce a 3Ј-coterminal nested set of polycistronic subgenomic mRNAs (sgmRNAs) synthesized by a discontinuous transcription process during the synthesis of the negative strand (36, 37). The sgmRNAs contain identical 5Ј ends due to the addition of a leader sequence derived from the 5Ј end of the genomic RNA (gRNA). Preceding the body sequence of each sgmRNA sequence on the gRNA is a consensus sequence, the transcription-associated sequence (TAS) (20), involved in the acquisition of the leader sequence. All coronavirus envelopes contain at least three membrane proteins, the spike glycoprotein, a small membrane protein, and an integral membrane protein. In addition, the coronavirus virion also contains a nucleocapsid protein that interacts with the gRNA.
Avian infectious bronchitis virus (IBV), a group 3 member of the genus Coronavirus (order Nidovirales, family Coronaviridae), is a highly infectious pathogen of domestic fowl that replicates primarily in the respiratory tract but also in epithelial cells of the gut, kidney, and oviduct (10, 13, 14) . Genetically very similar coronaviruses cause disease in turkeys and pheasants (11, 12) . Coronaviruses are enveloped viruses that replicate in the cell cytoplasm and contain an unsegmented, 5Ј-capped and 3Ј-polyadenylated, single-stranded, positive-sense RNA genome of 28 to 32 kb (16, 25, 38) . During the replication cycle, coronaviruses produce a 3Ј-coterminal nested set of polycistronic subgenomic mRNAs (sgmRNAs) synthesized by a discontinuous transcription process during the synthesis of the negative strand (36, 37) . The sgmRNAs contain identical 5Ј ends due to the addition of a leader sequence derived from the 5Ј end of the genomic RNA (gRNA). Preceding the body sequence of each sgmRNA sequence on the gRNA is a consensus sequence, the transcription-associated sequence (TAS) (20) , involved in the acquisition of the leader sequence. All coronavirus envelopes contain at least three membrane proteins, the spike glycoprotein, a small membrane protein, and an integral membrane protein. In addition, the coronavirus virion also contains a nucleocapsid protein that interacts with the gRNA.
Coronavirus defective RNAs (D-RNAs), which lack large parts of the genome, are produced following virus passage at a high multiplicity of infection. While all D-RNAs contain cisacting sequences necessary for replication, only a subset of D-RNAs contain sequences necessary for packaging into virions in the presence of a helper virus. Coronavirus D-RNAs have been used for site-directed mutagenesis of virus genomes (29) and for the expression of heterologous genes in helperdependent expression systems (1, 2, 15, 17, 18, 21, 24, 26, 27, 40, 41, 44, 45) . Heterologous gene expression by coronavirus D-RNAs has required an appropriate TAS for the synthesis of a D-RNA-derived sgmRNA, which is subsequently translated in a cap-dependent manner. We have routinely used the IBV Beaudette gene 5 TAS for the expression of heterologous genes from IBV-derived D-RNAs. The Beaudette gene 5 TAS was chosen because it has the shortest sequence between the 3Ј end of the TAS and the AUG of open reading frame (ORF) 5a and because the Beaudette sgmRNA 5 is one of the most abundantly expressed sgmRNAs (40) . The IBV Beaudette gene 5 TAS consists of two canonical consensus sequences (CUUAACAA) in a tandem repeat and has been used to express the chloramphenicol acetyltransferase (CAT) and luciferase (Luc) reporter genes (17, 40) and chicken gamma interferon (IFN-␥) (18) . Internal ribosome entry site (IRES) sequences allow translation to occur internally within an RNA via a cap-independent mechanism by recruiting the eukaryotic initiation factors, initiator tRNA, ribosomal subunits, and other cellular factors (5, 19, 28) . The first IRES was identified in the poliovirus genome (31) , resulting in the development of bicistronic expression vectors usually utilizing an IRES sequence from either polio-virus or encephalomyocarditis virus (EMCV) (22) . The inclusion of an IRES to initiate heterologous gene translation within a coronavirus D-RNA should obviate the need to generate specific sgmRNAs for the expression of heterologous genes by allowing translation directly from the D-RNA. In this study, we describe experiments to determine the feasibility of utilizing EMCV IRES-mediated internal initiation for CAT protein synthesis from IBV D-RNAs during IBV helper virusdependent rescue.
MATERIALS AND METHODS
Cells and viruses. IBV Beaudette was grown in 11-day-old embryonated specific-pathogen-free domesticated fowl eggs, harvested from allantoic fluid 20 h postinfection, and used as helper virus for the rescue of IBV D-RNAs (41) . IBV was passaged in primary chick kidney (CK) cells (32) . Fowlpox virus FPV/T7, a recombinant expressing the bacteriophage T7 DNA-dependent RNA polymerase under the control of the vaccinia virus P 7.5 early-late promoter (8) , was grown in chicken embryonic fibroblasts (17) .
Oligonucleotides. All oligonucleotides used in this work were obtained from MWG-Biotech and are listed on Table 1 .
Recombinant DNA techniques. Recombinant DNA techniques used standard procedures (3, 35) or were used according to the manufacturers' instructions. All IBV-related nucleotide and amino acid residue numbers refer to the positions in the IBV Beau-R genome (9), GenBank accession no. AJ311317.
Construction of D-RNAs. All of the D-RNAs ( Fig. 1 ) used were constructed by using the IBV D-RNA CD-61 cDNA sequence in pIBV-Vec (17) . The CD-61 cDNA in pIBV-Vec is under the control of a T7 promoter (T7) and is terminated downstream of the poly(A) tail by a hepatitis delta antigenome ribozyme (H␦R) and a T7 terminator (T7) sequence (17) . The CAT gene, under the control of the IBV Beaudette gene 5 TAS (TAS-CAT) (40) , was ligated into the PmaCI site of CD-61 in pIBV-Vec, producing pCD-61-CAT. The EMCV IRES sequence (a gift from Graham Belsham, IAH Pirbright Laboratory) was amplified by PCR with oligonucleotides EMCV-1 and EMCV-2 and ligated into pTarget (Promega), producing pIRES. Oligonucleotide EMCV-1 added NruI and Eco47III restriction sites on the 5Ј end of the EMCV IRES sequence, and oligonucleotide EMCV-2 added Eco47III, BglII, PacI, EcoRV, XhoI, and NruI restriction sites on the 3Ј end of the EMCV IRES sequence. The NruI-digested IRES sequence from pIRES was inserted into the StuI and PmaCI sites of CD-61 in pIBV-Vec, producing pCD-61-StuI-IRES and pCD-61-PmaCI-IRES, respectively. The CAT gene was amplified by PCR with oligonucleotides CAT-PAC and CAT-XHO and inserted into pTarget, producing pCAT. Oligonucleotides CAT-PAC and CAT-XHO added PacI and XhoI restriction sites to the 5Ј and 3Ј ends of the CAT sequence, respectively. PacI-XhoI-digested CAT sequence from pCAT was directionally inserted into the PacI and XhoI sites, downstream of the EMCV IRES sequence in pCD-61-StuI-IRES and pCD-61-PmaCI-IRES, producing pStuI-IRES-CAT (SIC) and pPmaCI-IRES-CAT (pPIC), respectively. The TAS-CAT gene cassette was amplified by PCR with oligonucleotides BGL2TAS5 and CAT-XHO, in which oligonucleotide BGL2TAS5 added a BglII restriction site to the 5Ј end of the TAS. The BglII-TAS-CAT-XhoI-digested PCR product was inserted into pPIC, producing pIRES-TAS-CAT (pITC).
Plasmid pPIC was digested with KpnI (within CD-61) and SpeI (within EMCV IRES) to remove a 1,744-bp fragment comprising 1,286 bp of CD-61 and 458 bp of the EMCV IRES, which was inserted into pBluescript, producing pBluescript-PIC. Oligonucleotides gene5ϩve and gene5Ϫve were annealed to create a 36-bp adapter, consisting of the IBV Beaudette gene 5 TAS and sequence between the TAS and the ORF 5a start codon, which was inserted into the Eco47III site proximal to the IRES sequence in pBluescript-PIC, producing pBluescript-TAS-PIC. A 1,780-bp SpeI-KpnI fragment was removed from pBluescript-TAS-PIC and used to replace the 1,744-bp SpeI-KpnI fragment in pPIC, producing pTAS-IRES-CAT (pTIC). The 36-bp adapter was inserted into the SnaBI site of pCD-61-CAT and pPIC, producing pCD-61-CAT-TAS-SnaBI (pCCT) and pPIC-TAS-SnaBI (pPT), respectively. Eco47III-digested EMCV IRES from pCD-61-PmaCI-IRES was religated back into the D-RNA sequence in the antisense orientation, producing pCD-61-IRESneg. Sequence analysis was used to confirm that the various sequences had been inserted correctly.
In vitro transcription/translation. An in vitro transcription/translation reaction was performed with a rabbit reticulocyte lysate-coupled transcription and translation cell-free protein synthesis system (Promega). Plasmid DNA (1 g) was added to 25 l of rabbit reticulocyte lysate, 2 l of reaction buffer, 1 l of T7 RNA polymerase (15 U/l), 2 l of 1 mM amino acid mixture, and 1 l of In situ transcription/translation. CK cells (70 to 80% confluent) in 25-cm 2 flasks were infected with FPV/T7 at a multiplicity of infection of 10 and incubated at 37°C for 2 h. The initial inoculum was replaced with 3 ml of CK cell media, and the cells were incubated at 37°C for an additional 2 h. The cells were transfected with 2 g of plasmid DNA, with Lipofectin transfection reagent (Invitrogen), and incubated in Opti-MEM serum-free medium (Invitrogen) at 37°C for 20 h.
Helper IBV rescue of D-RNAs. In vitro T7-derived transcripts were synthesized from 1 g of plasmid DNA and electroporated into IBV Beaudette-infected CK cells (P 0 ) (41) . Progeny virus (V 1 ) and any D-RNA from 1 ml of the P 0 CK cell medium were passaged on CK cells (P 1 ); this was repeated for two more passages (P 2 to P 3 ).
Identification of IBV-derived RNAs. Total cytoplasmic RNA was extracted from IBV-infected CK cells with RNeasy (Qiagen), electrophoresed in denaturing 1% agarose-2.2 M formaldehyde gels, and transferred to Hybond XL nylon membranes (Amersham). IBV-derived RNAs were detected by hybridization to a 309-bp IBV probe, covalently labeled with psoralen-biotin (BrightStar; Ambion), corresponding to the last 309 nucleotides at the 3Ј end of the IBV genome (17) . RNAs containing the EMCV IRES were detected by using a 573-bp Eco47III DNA fragment, covalently labeled with psoralen-biotin, corresponding to the EMCV IRES from pPIC. Hybridized probes were detected by using streptavidin-alkaline phosphatase as described in references 17 and 18.
Analysis of CAT protein. The CAT protein was detected by enzyme-linked immunosorbent assay (ELISA) (Boehringer Mannheim). Following rescue of D-RNAs in CK cells, approximately 2 ϫ 10 6 cells were scraped from the plastic into the cell culture medium, pelleted by centrifugation at 2,500 rpm (Beckman GS-15R), and lysed in 1 ml of lysis buffer (Boehringer Mannheim) (40) . For detection of CAT protein in the cell-free reactions, 150 l of lysis buffer was added to each 50 l of the in vitro reaction mixture sample. Following the addition of lysis buffer, all of the samples were incubated at room temperature for 30 min and the CAT protein was detected by ELISA (40) . Serial dilutions of the samples were made, and the amounts of CAT protein were determined by comparison to standard amounts of CAT protein. (17) were constructed by using three restriction sites in CD-61, SnaBI and StuI within domain II and PmaCI within domain III (33, 40) . The SnaBI and StuI sites are within the D-RNA-specific ORF (33) . Previous results had demonstrated that the expression of reporter genes from the SnaBI site did not affect the stability of the D-RNA any more than expression of reporter genes from the PmaCI site within domain III, which is not within the D-RNA-specific ORF (18, 40) . We have expressed a variety of heterologous genes, CAT (40) , Luc (17) and chicken IFN-␥ (18), from the PmaCI site under the control of TAS-directed coronavirus transcription. The introduction of these sequences did affect the stability of the D-RNAs. However, we were able to detect expression of the genes up to passage 10 (17, 18, 40) . The IRES-CAT sequences were inserted into the two different positions (StuI and PmaCI) within D-RNA CD-61 to determine whether there was any position-specific effect of the IRES sequence on either expression of CAT or stability of the resultant D-RNA. D-RNA CD-61-CAT, based on pIBV-Vec, was essentially identical to the D-RNA described in reference 40, which was shown to be capable of initiating CAT gene expression during D-RNA rescue, except that the IBV D-RNA cDNA was terminated by the H␦R-T7 sequence. D-RNAs StuI-IRES-CAT (SIC) and PmaCI-IRES-CAT (PIC) contained the CAT gene, under control of the EMCV IRES, in the StuI and PmaCI sites of CD-61, respectively. D-RNAs IRES-TAS-CAT (ITC) contained the IBV TAS between the IRES and CAT gene sequences, and TAS-IRES-CAT (TIC) contained the IBV TAS immediately proximal to the EMCV IRES sequence. D-RNAs ITC and TIC were constructed to ascertain whether an IRES sequence, in conjunction with an IBV TAS, could initiate CAT protein expression and whether expression of CAT, under both IRES and TAS control, would be more efficient then either alone. D-RNAs CD-61-CAT-TAS-SnaBI (CCT) and PIC-TAS-SnaBI (PT) contained a TAS sequence in the SnaBI site upstream of the TAS-CAT and IRES-CAT sequences, respectively, and were constructed to ascertain the effect of a distant distal TAS on CAT gene expression.
RESULTS

Insertion of EMCV IRES into IBV D-
In vitro assessment of IRES-mediated CAT translation. In vitro cell-free rabbit reticulocyte lysate-coupled transcription and translation assays were performed to determine whether IRES-mediated CAT translation could occur from IBV DRNAs. Plasmids representing the IRES-containing D-RNAs SIC, PIC, ITC, TIC, and PT all resulted in detectable levels of CAT protein ( Fig. 2A) . In contrast, plasmids representing DRNAs CD-61-CAT and CCT, containing the TAS-CAT cassette, and plasmids representing D-RNAs CD-61 and CD-61-PmaCI-IRES, which did not contain the CAT gene, did not, as expected, produce CAT protein ( Fig. 2A) . This verified that the CAT protein expressed from D-RNAs SIC, PIC, ITC, TIC, and PT was not due to ribosomal scanning from the 5Ј end of the T7-derived D-RNA transcripts. CAT protein expressed from the in vitro T7-transcribed D-RNAs resulted from EMCV IRES-mediated translation.
In situ assessment of IRES-mediated CAT translation. To determine whether the EMCV IRES could function in primary CK cells, plasmids representing the various D-RNAs were transfected into FPV/T7-infected CK cells for the in situ expression of T7-derived D-RNA transcripts. CAT protein was detected from plasmids representing the IRES-containing DRNAs, SIC, PIC, ITC, TIC, and PT (Fig. 2B) . In contrast, no detectable levels of CAT protein were identified, as expected, from plasmids representing D-RNAs CD-61, CD-61-CAT, CD-61-PmaCI-IRES, and CCT, or from mock-infected CK cells transfected with pPIC or pCD-61-CAT (Fig. 2B) . This demonstrated that detection of CAT protein in situ did not result from ribosomes binding to the 5Ј end of the T7-derived D-RNA transcripts and scanning through to the CAT gene. These results confirmed the in vitro cell-free expression results and demonstrated that the EMCV IRES sequence was capable of initiating CAT protein translation from within IBV D-RNAs in avian CK cells. The presence of the IBV TAS in D-RNAs TIC, ITC, and PT did not prevent IRES-mediated CAT translation in situ (Fig. 2B) . However, the amounts of CAT protein detected in CK cells from D-RNA ITC were 6.1-, 16.3-, 12.8-, and 12.4-fold lower than the amounts of CAT protein detected from D-RNAs SIC, PIC, TIC, and PT, respectively. This observation indicated that the IBV TAS, between the IRES and the CAT gene, had some detrimental effect on IRES-mediated translation in CK cells when compared to CAT expression following in vitro translation ( Fig. 2A) . (Fig. 3A) . This observation was in contrast to the in vitro and in situ expression results in which no CAT protein was detected from the CAT gene under the control of the IBV TAS but CAT, under the control of the EMCV IRES, was detected (Fig. 2) . This indicated that EMCV IRES-mediated translation may not occur in the presence of IBV. The observation that neither D-RNA SIC or PIC resulted in IRES-mediated CAT translation indicated that there was no position-specific effect of the IRES within the D-RNA sequence.
Assessment of IRES-mediated CAT translation following
To further investigate IRES-mediated CAT translation in the presence of IBV helper virus, in vitro T7-transcribed DRNAs were electroporated into Beaudette-infected CK cells and any progeny virus and D-RNA were serially passaged twice in CK cells (P 1 and P 2 ). CK cell lysates (P 0 to P 2 ) were assayed for the presence of CAT protein. With the exception of D-RNA ITC, none of the IRES-containing D-RNAs produced detectable amounts of CAT protein in the presence of helper IBV (Fig. 3B) . The two TAS-CAT-containing D-RNAs, CD-61-CAT and CCT, resulted in the expression of increasing amounts of CAT protein following rescue (replication and packaging) on serial passage of the D-RNAs as previously observed (40) . D-RNA ITC, containing the IBV TAS sequence between the IRES and CAT gene sequences, resulted in expression of CAT protein only in P 0 CK cells (Fig. 3B) (Fig. 3A) . A D-RNA, CD-61-IRESneg, containing the EMCV IRES in an antisense orientation was constructed (Fig. 5A) . The EMCV IRES is unable to initiate translation in an antisense orientation (23, 27, 34) . CD-61-IRESneg was used to determine whether the potential effect on the IBV replicase was due to an intrinsic property of the IRES sequence or whether the recruitment of ribosomes to the D-RNA was preventing efficient replication of the IRES-containing D-RNAs.
In RNAs were passaged three times (P 1 to P 3 ) in CK cells, and RNA was extracted from P 2 and P 3 cells and analyzed by Northern blot analysis. Analysis of the RNAs (Fig. 5B) showed that D-RNA CD-61 was rescued, with the highest amounts coming from P 3 CK cells. As anticipated, D-RNA CD-61-PmaCI-IRES was not rescued. D-RNA CD-61-IRESneg was not detected in RNAs from P 2 and P 3 CK cells, performed in three separate experiments (Fig. 5B) , demonstrating that IBV was unable to rescue a D-RNA with the EMCV IRES sequence in the antisense orientation. These results demonstrated that the recruitment of ribosomes by the IRES sequence was not responsible for affecting rescue of the IREScontaining D-RNAs. Therefore, the inability of IBV to rescue the IRES-containing D-RNAs must have resulted from some intrinsic property of the IRES sequence, most likely by having a detrimental effect on replication of the D-RNAs.
DISCUSSION
Expression of a heterologous gene from an IBV D-RNA, under the control of an IBV TAS, during helper-virus-dependent rescue requires D-RNA replication and synthesis of a D-RNA-derived sgmRNA and resulted in maximum protein expression by P 4 (15, 17, 18, 40) . Several rounds of passage were required to achieve maximal expression of the gene, but this resulted in eventual loss of the D-RNA. The expression of two heterologous genes, CAT (40) and chicken IFN-␥ (18), was not affected by the position of the insert within the sequence of D-RNA CD-61, indicating that there was no position-specific effect of the heterologous genes at the two positions used. One of the positions, SnaBI, is within domain II of CD-61 and interrupts the D-RNA-specific ORF, resulting from in-frame deletions during the generation of CD-61. The second site, PmaCI, is within domain III and does not interrupt the CD-61-specific ORF. The PmaCI site has been our preferred site for the insertion of heterologous genes. We decided to explore an alternative expression system by using the EMCV IRES to initiate internal translation from within a D-RNA. Such an approach would circumvent the necessity of having to generate TAS-mediated D-RNA-derived sgmRNAs for the expression of the required protein and would recruit the D-RNA as a template for translation. This would potentially increase initial expression levels without dependence on the efficiency of D-RNA-derived sgmRNA synthesis. The EMCV IRES has been used for cap-independent translation of many proteins and offers the opportunity to express proteins without the requirement of specialized transcription initiation sequences and signals.
The EMCV IRES was demonstrated to be capable of initiating CAT protein translation from T7-transcribed IBV DRNAs both in a mammalian-derived cell-free protein synthesis system and in situ in FPV/T7-infected CK cells. This indicated that the IRES was capable of initiating translation in the con- The inability of helper IBV to rescue any of the IREScontaining D-RNAs indicated that the presence of the IRES sequence was detrimental to replication. This conclusion was supported by the inability to rescue CD-61-IRESneg, which contained the IRES sequence in the antisense orientation, eliminating recruitment of ribosomes by the IRES sequence, as being responsible for preventing replication of the D-RNAs. Therefore, the most probable reason for the inability to rescue the IRES-containing D-RNAs was inhibition of helper IBVdependent replication of the D-RNAs as a result of some intrinsic property of the IRES sequence. As indicated above, this could be due to the IRES secondary structure inhibiting the IBV replicase complex for generation of either negative-or positive-sense transcripts or a combination of both. The alternative explanation, that IBV replicase complex could perturb the IRES structure preventing IRES-mediated translation, is unlikely, as this would have resulted in replication of the D-RNA without translation of CAT protein, whereas no replication of the IRES-containing D-RNAs was observed. We observed no position-specific effects of the IRES sequence; the IRES-CAT construct was found to be inactive in IBV-infected cells irrespective of its position in the CD-61 sequence.
From the results presented in this study, the most likely explanation for the lack of IRES-mediated CAT translation is the inability of the IBV replicase complex to replicate the IRES-containing D-RNAs. Previous coronavirus D-RNA expression vectors have displayed various levels of instability depending on the nature of the inserted sequence. Expression of the Luc reporter gene was more unstable and had a lower expression efficiency then ␤-glucuronidase or CAT reporter gene expression in transmissible gastroenteritis virus (TGEV) and IBV D-RNAs, respectively (21, 40) . Similarly, expression of hemagglutinin-esterase and murine IFN-␥, when expressed from MHV D-RNAs, was not detected beyond P 3 and P 4 , respectively (26, 44) . These observations would imply that some aspect of any heterologous sequence, either the primary sequence, secondary structure, or some tertiary interaction, can adversely affect the stability of the D-RNA or simply that the D-RNAs need to revert to their most stable form. The loss of an IBV D-RNA-expressing chicken IFN-␥ following serial passage was due to the production of new and presumably more stable D-RNAs (18) . A similar observation was made for TGEV D-RNAs (1, 2) . In all previous examples of the rescue of coronavirus D-RNAs containing heterologous gene sequences, some degree of replication was observed, indicating that the insertion sites of the heterologous sequences within the D-RNAs did not prevent replication of the D-RNA. There was no indication of any rescue of the IRES-containing DRNAs or expression of CAT, except for D-RNA ITC, indicating that the IRES sequence did not simply have a destabilizing effect on replication but caused complete abolition of D-RNA replication.
The lack of IRES-controlled gene translation from IBV DRNAs is contradictory to the results of Lin and Lai (27) , who detected EMCV IRES-initiated CAT protein expression from the MHV D-RNA DissF during helper-virus-dependent rescue at both P 0 and P 1 , although the D-RNA rescue efficiency was low. Following rescue of the D-RNA, CAT activity decreased 20-fold, accredited to a reduction in D-RNA packaging efficiency. However, another explanation, in light of the experiments conducted in this study, is that the IRES sequence was also detrimental to helper-virus-dependent replication of the MHV D-RNA. Lin and Lai (27) used an in situ approach for the rescue of the IRES-containing D-RNA utilizing vaccinia virus (vTF7-3) expressing T7 RNA polymerase. It was possible that vTF7-3 resulted in sufficient levels of the MHV D-RNA, rather than MHV-mediated replication; for low-efficiency rescue in P 1 cells, there was no report as to whether the D-RNA was detected and expressed CAT in P 2 cells.
Although our results indicate that the EMCV IRES had a detrimental effect on helper virus rescue of IBV D-RNAs, an equine arteritis virus (EAV) replicon (a self-replicating RNA), containing an EMCV IRES, has been shown to replicate and initiate translation of downstream genes (42, 43) . EAV is an arterivirus belonging to a group of viruses related to coronaviruses and within the order Nidovirales which have a similar mechanism to coronaviruses for generating sgmRNAs. Interestingly, no replication of the EAV replicon was detected when the IRES and associated gene were inserted in the antisense orientation (43) . A flavivirus (Kunjin) replicon, containing CAT under the control of the EMCV IRES, expressed CAT but replicated with reduced efficiency, 10-to 20-fold less, compared to a Kunjin replicon lacking the IRES CAT sequence (23) . Insertion of the IRES CAT sequence in the antisense orientation did not affect replication, compared to the control, but did not express CAT protein. Although the Flaviviridae family and Nidovirales order have different replication strategies, it appears that the EMCV IRES in the antisense orientation can have different effects on replication of different positive-sense RNA viruses. The observations that the EMCV IRES functions when part of an arterivirus replicon but prevents replication of coronavirus D-RNAs indicates that the IRES sequence may have to be part of the gRNA or replicon RNA for successful replication and IRES-mediated translation. It will be interesting to establish whether an EMCV IRES will be tolerated in a coronavirus gRNA or replicon.
